Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

IMPL - Impel Pharmaceuticals Inc

Close
0.2411
-0.173   -71.796%

Share volume: 858,521
Last Updated: Fri 15 Dec 2023 10:00:01 PM CET
Research and Development in Biotechnology (except Nanobiotechnology): -0.44%

PREVIOUS CLOSE
CHG
CHG%
$0.41
-0.17
-41.79%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2023-03-31 2023-06-30 2023-09-30
Fiscal Quarter Q1 2023 Q2 2023 Q3 2023
Report Date 2023-05-12 2023-08-18 2023-11-14
Total revenue 4.372 M 6.584 M 5.023 M
Cost of revenue 2.285 M 3.220 M 2.230 M
Gross profit 2.087 M 3.364 M 2.793 M
    61.19% -16.97%  
Operating expenses 25.040 M 19.468 M 15.604 M
Selling general and admin 0.000 0.000 0.000
Research and development 25.040 M 19.468 M 15.604 M
Total expenses 27.325 M 22.688 M 17.834 M
    -16.97% -21.39%  
Operating income -22.953 M -16.104 M -12.811 M
Ebit -22.953 M -16.104 M -12.811 M
Pretax income -30.067 M -7.357 M -13.814 M
    -75.53% 87.77%  
Income tax 0.000 0.000 0.000
Net income basic -30.067 M -7.357 M -13.814 M
    75.53% -87.77%  
Net income -30.067 M -7.357 M -13.814 M
    75.53% -87.77%